Practice of reusing dialysis filters for kidney patients in Chile comes to an end
要点
- ASODIBIOBIO and Deputy Paz Charpentier met with the Chilean Minister of Health to discuss the challenges faced by kidney patients.
- The decision to end the reuse of dialysis filters was evaluated by patient organizations as a major gain in terms of safety and quality.
- In the GES Renal 2027 plan, it is requested that high-volume hemodiafiltration treatment (HvHDF) be included in the system for more complex patients.
- New treatment methods supported by scientific evidence are expected to benefit approximately 3,100 patients and cover about 12% of dialysis patients.
数字で見る
The Biobío Region Kidney and Transplant Patients Association (ASODIBIOBIO) and Deputy Paz Charpentier met with the Chilean Minister of Health to address the current challenges encountered in the management of chronic kidney disease. At the meeting, the decision to end the practice of reusing dialysis filters was welcomed as a prominent development.
Deputy Charpentier described the end of this outdated method, which compromised patient safety and allowed filters to be reused up to 26 times, as a significant step. Furthermore, ASODIBIOBIO emphasized that innovative treatment methods, such as high-volume hemodiafiltration (HvHDF), need to be integrated into the system during the update process of the GES Renal 2027 plan.
It was noted that completing the coding and evaluation processes is critical for the inclusion of new treatment methods. The association believes that these developments will improve the quality of life for chronic kidney patients and help make the public health system in Chile safer.
リアクション
この記事について質問
回答はこの記事のみからAIが生成します。
よくある質問
- Why was the reuse of dialysis filters ended?
- Using the filters more than once is a situation that seriously endangers patient safety. The practice was ended to eliminate life-threatening risks arising from this situation and to provide quality healthcare.
- How will the new type of dialysis treatment (HvHDF) affect patient health?
- High-volume hemodiafiltration (HvHDF) stands out as an additional option for patients with more severe conditions requiring complex treatment. Evidence shows that this method improves clinical outcomes.
- What is GES Renal 2027 and why is it important?
- GES Renal 2027 is an updated health coverage plan that sets the standards for healthcare services received by kidney patients in Chile. This plan is of great importance for the incorporation of new practices into the system, which are expected to increase the quality of treatment.